Year 2018 / Volume 110 / Number 8
Original
Self-expandable metal stents are a valid option in long-term survivors of advanced esophageal cancer

500-504

DOI: 10.17235/reed.2018.5323/2017

Eduardo Rodrigues-Pinto, Pedro Pereira, Todd H. Baron, Guilherme Macedo,

Abstract
Background: self-expandable metal stents are often used for the palliative treatment of dysphagia in patients with advanced esophageal cancer and an anticipated limited survival. Due to previous reports of a high rate of adverse event when used long-term, concerns have been raised with regard to the use of self-expandable metal stents in patients with a longer survival. Aim: assess the role of esophageal self-expandable metal stents in patients with advanced esophageal cancer that have survived longer than six months. Methods: retrospective study of patients with advanced esophageal cancer with a self-expandable metal stent and a stent placement time greater than six months. Results: forty-two patients were followed up for 298 days. There was a clinical improvement in all patients. However, 59% of patients experienced an adverse event. The median stent patency was 236 days. Endoscopic management was attempted in all self-expandable metal related adverse events, with a clinical success rate of 100%. However, the previously treated adverse event recurred in seven patients. Multivariate analysis showed that strictures that were traversable with an ultrathin gastroscope were associated with a higher risk of adverse events (p = 0.035). Conclusions: long-term esophageal stenting in patients with advanced esophageal cancer is associated with a high prevalence of adverse events without an impact on mortality; most cases can be managed endoscopically.
Share Button
New comment
Comments
No comments for this article
References
1. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74-108.
2. Pisani P, Parkin DM, Bray F, et al. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer. 1999;83:18-29.
3. Stein HJ, Siewert JR. Improved prognosis of resected esophageal cancer. World J Surg. 2004;28:520-5.
4. McManus K, Khan I, McGuigan J. Self-expanding oesophageal stents: strategies for re-intervention. Endoscopy. 2001;33:601-4.
5. Vakil N, Morris AI, Marcon N, et al. A prospective, randomized, controlled trial of covered expandable metal stents in the palliation of malignant esophageal obstruction at the gastroesophageal junction. Am J Gastroenterol. 2001;96:1791-6.
6. Siersema PD. Treatment options for esophageal strictures. Nat Clin Pract Gastroenterol Hepatol. 2008;5:142-52.
7. Homs MY, Steyerberg EW, Eijkenboom WM, et al. Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial. Lancet. 2004;364:1497-504.
8. Rodrigues-Pinto E, Pereira P, Coelho R, et al. Outcome and risk factors assessment for adverse events in advanced esophageal cancer patients after self-expanding metal stents placement. Dis Esophagus. 2017;30:1-6.
9. Schoppmann SF, Langer FB, Prager G, et al. Outcome and complications of long-term self-expanding esophageal stenting. Dis Esophagus. 2013;26:154–8.
10. Kucera S, Barthel J, Klapman J, et al. Small caliber covered self-expanding metal stents in the management of malignant dysphagia. J Gastrointest Oncol 2016;7:411.
11. Spaander MC, Baron TH, Siersema PD, et al. Esophageal stenting for benign and malignant disease: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline. Endoscopy. 2016;48:939-48.
12. Fuccio L, Mandolesi D, Farioli A, et al. Brachytherapy for the palliation of dysphagia owing to esophageal cancer: A systematic review and meta-analysis of prospective studies. Radiother Oncol 2017;122:332-339.
13. Peters JH, Meester TR, Stein HJ. Surgical therapy for cancer of the esophagus and cardia. In: Castell DO; Ed. The Esophagus, 2nd ed. New York: Little, Brown. 1995: p. 293-335.
14. Dai Y, Li C, Xie Y, et al. Interventions for dysphagia in oesophageal cancer. Cochrane Database Syst Rev. 2014 Oct 30;(10):CD005048.
15. Bedenne L, Michel P, Bouché O, et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol. 2007;25:1160-8.
16. Conio M, Repici A, Battaglia G, et al. A randomized prospective comparison of self-expandable plastic stents and partially covered self-expandable metal stents in the palliation of malignant esophageal dysphagia. Am J Gastroenterol. 2007;102:2667-77.
17. Verschuur EM, Steyerberg EW, Kuipers EJ, et al. Effect of stent size on complications and recurrent dysphagia in patients with esophageal or gastric cardia cancer. Gastrointest Endosc. 2007;65:592-601.
18. Knyrim K, Wagner HJ, Bethge N, et al. A controlled trial of an expansile metal stent for palliation of esophageal obstruction due to inoperable cancer. N Engl J Med. 1993;329:1302-7.
19. Burstow M, Kelly T, Panchani S, et al. Outcome of palliative esophageal stenting for malignant dysphagia: a retrospective analysis. Dis Esophagus. 2009;22:519-25.
20. Siersema PD, Hop WC, van Blankenstein M, et al. A comparison of 3 types of covered metal stents for the palliation of patients with dysphagia caused by esophagogastric carcinoma: a prospective, randomized study. Gastrointest Endosc. 2001;54:145-53.
21. Hirdes MM, Siersema PD, Vleggaar FP. A new fully covered metal stent for the treatment of benign and malignant dysphagia: a prospective follow-up study. Gastrointest Endosc. 2012;75:712-8.
22. Walter D, van den Berg MW, van Hooft JE, et al. A new fully covered metal stent with anti-migration features for the treatment of malignant dysphagia. Endoscopy. 2014;46:1101-5.
23. Spaander MC. Do we need to fixate a fully covered esophageal metal stent? Endoscopy. 2016;48:787-8.
24. Medeiros VS, Martins BC, Lenz L, et al. Adverse events of self-expandable esophageal metallic stents in patients with long-term survival from advanced malignant disease. Gastrointest Endosc. 2017;86:299-306.
Related articles
Citation tools
Rodrigues-Pinto E, Pereira P, Baron T, Macedo G. Self-expandable metal stents are a valid option in long-term survivors of advanced esophageal cancer. 5323/2017


Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Metrics
This article has received 150 visits.
This article has been downloaded 143 times.

Statistics from Dimensions


Statistics from Plum Analytics

Publication history

Received: 18/10/2017

Accepted: 26/02/2018

Online First: 24/04/2018

Published: 30/07/2018

Article revision time: 125 days

Article Online First time: 188 days

Article editing time: 285 days


Share
This article hasn't been rated yet.
Reader rating:
Valora este artículo:




Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
The Spanish Journal of Gastroenterology is the official organ of the Sociedad Española de Patología Digestiva, the Sociedad Española de Endoscopia Digestiva and the Asociación Española de Ecografía Digestiva
Cookie policy Privacy Policy Legal Notice © Copyright 2023 y Creative Commons. The Spanish Journal of Gastroenterology